Skip to main content
FinSpry Logo
FinSpry
NVCR logo
NVCR
(NASDAQ)
NovoCure Limited
$19.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NovoCure (NVCR) Stock Price & Financial Analysis

NovoCure Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.00 - $20.55
52-Week High$20.55
52-Week Low$9.82
Open$18.00
Volume8.93M
Average Volume (3M)1.83M
Market Cap2.28B
Shares Outstanding114.15M
Price to Sales (P/S)3.38
Price to Book (P/B)6.90
EV/EBITDA-17.93
Revenue (TTM)674.41M
Net Income (TTM)-173.05M
Free Cash Flow (TTM)-48.07M
EPS (TTM)$-1.54
Profit Margin-25.66%
Operating Margin-27.19%
Return on Equity (ROE)-52.32%
Debt to Equity0.59
50-Day MA$16.74
200-Day MA$13.73
52-Week Change21.08%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NovoCure

What is the current stock price for NVCR?

As of the latest trading session, NVCR stock trades at $19.99. The 52-week range is $9.82–$20.55, with a day range of $18.00–$20.55.

What is the P/E ratio for NVCR?

The P/E ratio (Price-to-Earnings) for NVCR is shown in the Key Statistics section. This valuation metric helps compare NovoCure Limited to industry peers.

Does NVCR pay dividends?

NovoCure does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NVCR?

Based on 6 analysts, the consensus for NVCR is Buy.

What is the market cap of NVCR?

NovoCure's market capitalization is $2.28B, classifying it as a mid-cap company. NovoCure operates in the Healthcare sector within the Medical Devices industry.